2023~2025

1. 2025

   Hyundai Bioscience USA Inc. Granted Full Membership in the Medical CBRN
   Defense Consortium (MCDC) Under the U.S. Department of Defense

2. 2025

   CP-COV03 COVID-19 Clinical Results Published in Nature Communications

3. 2025

   Approval Granted for Phase 2/3 Dengue Clinical Trial in Vietnam

4. 2025

   Approval Granted for Phase 1 Clinical Trial in Korea for Castration-Resistant Prostate Cancer

5. 2025

   Seoul Office Relocated to Magok

6. 2024

   Acquisition of ADM Korea Inc. (Renamed Penetrium Bioscience Inc.)

7. 2024

   MOU Signed with Vietnam’s National Hospital for Tropical Diseases (NHTD)
   for Collaboration on Dengue Clinical Trials

8. 2023

   Completion of Integrated COVID-19 Clinical Trial for CP-COV03

2019~2022

1. 2022

   Establishment of Hyundai Bioscience USA Inc., the Company’s U.S. Subsidiary

2. 2022

   Approval Granted for Integrated Phase 2/3 Clinical Trial of CP-COV03

3. 2022

   Production Partnership Agreement Signed with Dongkook Pharmaceutical Co.,
   Ltd. for CP-COV03

4. 2021

   Exclusive Sales and Marketing Agreement in Korea Signed with CMG
   Pharmaceutical for 'VITABRID C¹²'

5. 2021

   Approval Granted for Phase 1 Clinical Trial of CP-COV03

6. 2021

   Manufacturing Agreement Signed with YOOYOUNG Pharm. Co., Ltd. for CP-COV03

2017~2018

1. 2018

   Company Renamed Hyundai Bioscience Co., Ltd.

2. 2017

   VITABRID C¹² HAIR Approved as a Quasi-Drug in Japan

3. 2017

   Expansion of the Gimcheon Bio Plant in Gyeongbuk Completed

4. 2017

   Exclusive Supply Agreement Signed for Vitabrid C¹² in Russia

5. 2017

   Vitabrid Launched at 11 Barneys New York Stores in the U.S.,
   Becoming the First Korean Brand to Do So

6. 2017

   PEPTIBRID Registered in the International Cosmetic Ingredient Dictionary

7. 2017

   Development of Anti-Inflammatory Drug Delivery Technology Completed

2012~2016

1. 2016

   Vitabrid C¹² SKIN Received the Monde Selection Grand Gold Award

2. 2016

   Vitabrid C¹² Face Brightening Powder Received the Trendsetter
   Award at Cosmoprof North America in Las Vegas

3. 2016

   Vitabrid C¹² Was Named the Most Innovative Brand of the Year by BeautyStreams

4. 2015

   Vitabrid C¹² HAIR Selected for the 2015 Korea INNO-STAR 100 by KMAR

5. 2015

   Completion of the Gimcheon Bio Plant

6. 2014

   Establishment of the Hyundai IBT–Ewha Womans University Bio Convergence
   Research Institute

7. 2012

   Launch of Vitabrid C¹²

2000~2011

1. 2010

   Company Renamed Hyundai IBT Co., Ltd.

2. 2004

   Received the USD 300 Million Export Tower Award at the 41st Trade Day

3. 2002

   Listed on KOSDAQ

4. 2000

   Spun Off from Hyundai Electronics and Established Hyundai IT